AIM ImmunoTech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AIM ImmunoTech and other ETFs, options, and stocks.

About AIM

AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. 

CEO
Thomas Kenwood Equels
CEOThomas Kenwood Equels
Employees
23
Employees23
Headquarters
Ocala, Florida
HeadquartersOcala, Florida
Founded
1966
Founded1966
Employees
23
Employees23

AIM Key Statistics

Market cap
3.00M
Market cap3.00M
Price-Earnings ratio
-0.04
Price-Earnings ratio-0.04
Dividend yield
Dividend yield
Average volume
201.78K
Average volume201.78K
High today
$0.72
High today$0.72
Low today
$0.6702
Low today$0.6702
Open price
$0.677
Open price$0.677
Volume
59.92K
Volume59.92K
52 Week high
$35.96
52 Week high$35.96
52 Week low
$0.6141
52 Week low$0.6141

Stock Snapshot

The current AIM ImmunoTech(AIM) stock price is $0.72, with a market capitalization of 3M. The stock trades at a price-to-earnings (P/E) ratio of -0.04.

As of 2026-03-14, AIM ImmunoTech(AIM) stock has fluctuated between $0.67 and $0.72. The current price stands at $0.72, placing the stock +7.4% above today's low and 0.0% off the high.

AIM ImmunoTech(AIM) shares are trading with a volume of 59.92K, against a daily average of 201.78K.

During the past year, AIM ImmunoTech(AIM) stock moved between $0.61 at its lowest and $35.96 at its peak.

During the past year, AIM ImmunoTech(AIM) stock moved between $0.61 at its lowest and $35.96 at its peak.

People also own

Based on the portfolios of people who own AIM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.